These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21291413)

  • 1. Learning monotonic genotype-phenotype maps.
    Beerenwinkel N; Knupfer P; Tresch A
    Stat Appl Genet Mol Biol; 2011; 10():Article 3. PubMed ID: 21291413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution on distributive lattices.
    Beerenwinkel N; Eriksson N; Sturmfels B
    J Theor Biol; 2006 Sep; 242(2):409-20. PubMed ID: 16650439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the dynamics and dependencies of accumulating mutations with applications to HIV drug resistance.
    Montazeri H; Günthard HF; Yang WL; Kouyos R; Beerenwinkel N;
    Biostatistics; 2015 Oct; 16(4):713-26. PubMed ID: 25979750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accommodating uncertainty in a tree set for function estimation.
    Healy BC; DeGruttola VG; Hu C
    Stat Appl Genet Mol Biol; 2008; 7(1):Article5. PubMed ID: 18312210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model selection for mixtures of mutagenetic trees.
    Yin J; Beerenwinkel N; Rahnenführer J; Lengauer T
    Stat Appl Genet Mol Biol; 2006; 5():Article17. PubMed ID: 17049028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of an in vivo fitness landscape experienced by HIV-1 under drug selective pressure useful for prediction of drug resistance evolution during treatment.
    Deforche K; Camacho R; Van Laethem K; Lemey P; Rambaut A; Moreau Y; Vandamme AM
    Bioinformatics; 2008 Jan; 24(1):34-41. PubMed ID: 18024973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombination and drug resistance in HIV: population dynamics and stochasticity.
    Kouyos RD; Fouchet D; Bonhoeffer S
    Epidemics; 2009 Mar; 1(1):58-69. PubMed ID: 21352751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agent-based model of genotype editing.
    Huang CF; Kaur J; Maguitman A; Rocha LM
    Evol Comput; 2007; 15(3):253-89. PubMed ID: 17705779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV evolutionary dynamics within and among hosts.
    Lemey P; Rambaut A; Pybus OG
    AIDS Rev; 2006; 8(3):125-40. PubMed ID: 17078483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining cross-sectional and prospective data methods to improve transition parameter estimation for characterizing the accumulation of HIV-1 drug resistance mutations.
    Healy B; De Gruttola V; Pagano M
    Biometrics; 2007 Sep; 63(3):742-50. PubMed ID: 17403101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of HIV-1 drug susceptibility phenotype from the viral genotype using linear regression modeling.
    Vermeiren H; Van Craenenbroeck E; Alen P; Bacheler L; Picchio G; Lecocq P;
    J Virol Methods; 2007 Oct; 145(1):47-55. PubMed ID: 17574687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-parametric methods to predict HIV drug susceptibility phenotype from genotype.
    DiRienzo AG; DeGruttola V; Larder B; Hertogs K
    Stat Med; 2003 Sep; 22(17):2785-98. PubMed ID: 12939786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid evolutionary escape by large populations from local fitness peaks is likely in nature.
    Weinreich DM; Chao L
    Evolution; 2005 Jun; 59(6):1175-82. PubMed ID: 16050095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombination in HIV and the evolution of drug resistance: for better or for worse?
    Bretscher MT; Althaus CL; Müller V; Bonhoeffer S
    Bioessays; 2004 Feb; 26(2):180-8. PubMed ID: 14745836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the comparison of artificial network and interpretation systems based on genotype resistance mutations in HIV-1-infected patients.
    Flandre P; Costagliola D
    AIDS; 2006 Oct; 20(16):2118-20. PubMed ID: 17053360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of recombination on the neutral evolution of genetic robustness.
    Szöllosi GJ; Derényi I
    Math Biosci; 2008; 214(1-2):58-62. PubMed ID: 18490032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hierarchical fair competition (HFC) framework for sustainable evolutionary algorithms.
    Hu J; Goodman E; Seo K; Fan Z; Rosenberg R
    Evol Comput; 2005; 13(2):241-77. PubMed ID: 15969902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HIV resistance testing. Introduction of a new technique].
    Dragsted UB; Benfield TL
    Ugeskr Laeger; 2002 Apr; 164(17):2263-7. PubMed ID: 11989174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A model of directional selection applied to the evolution of drug resistance in HIV-1.
    Seoighe C; Ketwaroo F; Pillay V; Scheffler K; Wood N; Duffet R; Zvelebil M; Martinson N; McIntyre J; Morris L; Hide W
    Mol Biol Evol; 2007 Apr; 24(4):1025-31. PubMed ID: 17272680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Joint modeling of progression of HIV resistance mutations measured with uncertainty and failure time data.
    Hu C; De Gruttola V
    Biometrics; 2007 Mar; 63(1):60-8. PubMed ID: 17447930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.